INR Advisory Services’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
$3K Hold
83
﹤0.01% 55
2018
Q4
$3K Buy
+83
New +$3.45K ﹤0.01% 59
2018
Q3
Sell
-80
Closed -$3K 84
2018
Q2
$3K Buy
+80
New +$2.73K ﹤0.01% 69
2017
Q2
Sell
-42,519
Closed -$1.38M 110
2017
Q1
$1.38M Hold
42,519
0.22% 15
2016
Q4
$1.31M Buy
42,519
+5,270
+14% +$161K 0.22% 17
2016
Q3
$1.2M Hold
37,249
0.21% 19
2016
Q2
$1.24M Hold
37,249
0.23% 12
2016
Q1
$1.05M Hold
37,249
0.19% 18
2015
Q4
$1.14M Hold
37,249
0.22% 16
2015
Q3
$1.11M Sell
37,249
-79
-0.2% -$2.53K 0.23% 16
2015
Q2
$1.19M Buy
37,328
+79
+0.2% +$2.58K 0.23% 15
2015
Q1
$1.23M Hold
37,249
0.22% 12
2014
Q4
$1.1M Hold
37,249
0.21% 18
2014
Q3
$1.04M Hold
37,249
0.22% 20
2014
Q2
$1.05M Hold
37,249
0.22% 19
2014
Q1
$1.14M Hold
37,249
0.25% 18
2013
Q4
$1.08M Hold
37,249
0.25% 17
2013
Q3
$1.01M Hold
37,249
0.27% 17
2013
Q2
$990K Buy
+37,249
New +$1.03M 0.27% 17

Other funds holding PFE

INR Advisory Services's PFE Position: Q1 2019 in Review

INR Advisory Services held its Pfizer (PFE) position steady in Q1 2019 at 83 shares worth $3K. The position accounts for ﹤0.01% of the portfolio, ranked #55.

INR Advisory Services first reported a position in PFE in Q2 2013 and has held it in 19 quarters since. The position peaked at $1.38M in Q1 2017. 2,392 funds tracked by Wall St. Rank hold PFE as of Q1 2019.

  • INR Advisory Services held 83 shares of Pfizer worth $3K as of Q1 2019.
  • INR Advisory Services left its Pfizer share count unchanged in Q1 2019.
  • Pfizer made up ﹤0.01% of INR Advisory Services's portfolio in Q1 2019, its #55 holding.
  • INR Advisory Services first reported a position in Pfizer in Q2 2013 and has held it in 19 quarters since.
  • INR Advisory Services's Pfizer position peaked at $1.38M in Q1 2017.
  • 2,392 funds tracked by Wall St. Rank held Pfizer as of Q1 2019.

Based on INR Advisory Services's 13F filing for Q1 2019, filed 22 Apr 2019.